Abstract
Bone marrow derived mesenchymal stem cells (BM-MSCs) take part in the colonic mucosal regeneration. They are multipotent cells, which can be identified with both negative (i.e. CD13, CD 14, CD45, c-Kit, major histocompatibility complex /MHC class I and II) and positive (i.e. CD54 (ICAM1), CD133, CD146 (MCAM), CD166, Flk-1, Sca-1, Thy-1, stage-specific antigen I /SSEA-I and Musashi-1, HLA class I) markers. These cells can repopulate the gastrointestinal mucosa as they may differentiate into stromal- (i.e. myofi-broblast) or epithelial-like (Paneth-, epithel-, goblet or enteroendocrin) cells without proliferation. During the mesenchymal to epithelial transition (MET) stem cells enter the epithelial layer and take up epithelial cell-like properties. Rarely BM-MSCs may retain their stem cell characteristics and are capable of producing progeny. The isolated lymphoid aggregates may serve as a platform from where BM-MSCs migrate to the nearby crypts as mediated by several chemoattractant proteins, which are expressed in injured tissue. The number of BM-MSCs is influenced by the degree of inflammation. In this review we summarize the current information about the role of BM-MSCs in the repair progress of injured colonic epithelium and their potential clinical applications.
Similar content being viewed by others
References
Grove JE, Bruscia E, Krause DS (2004) Plasticity of bone marrow-derived stem cells. Stem Cells 22:487–500
Potten CS, Loeffler M (1990) Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110:1001–1020
Matsumoto T, Okamoto R, Yajima T et al (2005) Increase of bone marrow-derived secretory lineage epithelial cells during regeneration in the human intestine. Gastroenterology 128:1851–1867
Brittan M, Wright NA (2004) Stem cell in gastrointestinal structure and neoplastic development. Gut 53:899–910
Tanaka F, Tominaga K, Ochi M et al (2008) Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci 83:771–779
Wei Y, Nie Y, Lai J et al (2009) Comparison of the population capacity of hematopoietic and mesenchymal stem cells in experimental colitis rat model. Transplantation 88:42–48
De Wever O, Demetter P, Mareel M et al (2008) Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123:2229–2238
Brittan M, Hunt T, Jeffery R et al (2002) Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut 50:752–757
Barry FP, Murphy JM (2004) Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36:568–584
Spees JL, Olson SD, Ylostalo J et al (2003) Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci U S A 100:2397–2402
Minguell JJ, Erices A, Conget P (2001) Mesenchymal stem cells. Exp Biol Med (Maywood) 226:507–520
Patel SA, Sherman L, Munoz J et al (2008) Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp (Warsz) 56:1–8
Jiang Y, Jahagirdar BN, Reinhardt RL et al (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41–49
Kassem M, Kristiansen M, Abdallah BM (2004) Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 95:209–214
Matsumoto T, Okamoto R, Yajima T et al (2005) Increase of bone marrow-derived secretory lineage epithelial cells during regeneration in the human intestine. Gastroenterology 128:1851–1867
Phinney DG, Prockop DJ (2007) Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair current views. Stem Cells 25:2896–2902
Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Baksh D, Yao R, Tuan RS (2007) Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384–1392
Haasters F, Prall WC, Anz D et al (2009) Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing. J Anat 214:759–767
Mansilla E, Marín GH, Drago H et al (2006) Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc 38:967–969
Gargett CE, Schwab KE, Zillwood RM et al (2009) Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod 80:1136–1145
Satija NK, Gurudutta GU, Sharma S et al (2007) Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev 16:7–23
Leedham SJ, Brittan M, McDonald SA et al (2005) Intestinal stem cells. J Cell Mol Med 9:11–24
Chamberlain G, Fox J, Ashton B et al (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739–2749
Okamoto R, Yajima T, Yamazaki M et al (2002) Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med 8:1011–1017
Li C, Kong Y, Wang H et al (2009) Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 50:1174–1183
Liu ZJ, Zhuge Y, Velazquez OC (2009) Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 106:984–991
Liu N, Chen R, Du H et al (2009) Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells. Cell Mol Immunol 6:207–213
Kim YS, Park HJ, Hong MH et al (2009) TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium. Front Biosci 14:2845–2856
Yabana T, Arimura Y, Tanaka H et al (2009) Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity. J Pathol 218:350–359
Komori M, Tsuji S, Tsujii M et al (2005) Involvement of bone marrow-derived cells in healing of experimental colitis in rats. Wound Repair Regen 13:109–118
Emura M, Ochiai A, Horino M et al (2000) Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1. In Vitro Cell Dev Biol Anim 36:77–80
Brenmoehl J, Miller SN, Hofmann C et al (2009) Transforming growth factor-beta 1 induces intestinal myofibroblast differentiation and modulates their migration. World J Gastroenterol 15:1431–1442
Beck PL, Rosenberg IM, Xavier RJ et al (2003) Transforming growth factor-beta mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am J Pathol 162:597–608
Roufosse CA, Direkze NC, Otto WR et al (2004) Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36:585–597
Andoh A, Bamba S, Fujiyama Y et al (2005) Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response. J Gastroenterol 40:1089–1099
Brittan M, Chance V, Elia G et al (2005) A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology 128:1984–1995
Powell DW, Mifflin RC, Valentich JD et al (1999) Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277:1–9
Powell DW, Mifflin RC, Valentich JD et al (1999) Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 277:183–201
Baum B, Settleman J, Quinlan MP (2008) Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19:294–308
Saxena SK, Thompson JS, Sharp JG (1997) Role of organized intestinal lymphoid aggregates in intestinal regeneration. J Invest Surg 10:97–103
Chugh AR, Zuba-Surma EK, Dawn B (2009) Bone marrow-derived mesenchymal stems cells and cardiac repair. Minerva Cardioangiol 57:185–202
Sugaya K, Merchant S (2008) How to approach Alzheimer’s disease therapy using stem cell technologies. J Alzheimers Dis 15:241–254
Le Visage C, Dunham B, Flint P et al (2004) Coculture of mesenchymal stem cells and respiratory epithelial cells to engineer a human composite respiratory mucosa. Tissue Eng 10:1426–1435
Powell DW, Adegboyega PA, Di Mari JF et al (2005) Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Physiol Gastrointest Liver Physiol 289:2–7
Rubio D, Garcia S, De la Cueva T et al (2008) Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition. Exp Cell Res 314:691–698
Houghton J, Wang TC (2005) Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128:1567–1578
Panés J, Salas A (2009) Mechanisms underlying the beneficial effects of stem cell therapies for inflammatory bowel diseases. Gut 58:898–900
Khalil PN, Weiler V, Nelson PJ et al (2007) Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology 132:944–954
Asari S, Itakura S, Ferreri K et al (2009) Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol 37:604–615
Ringdén O, Uzunel M, Rasmusson I et al (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390–1397
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Valcz, G., Krenács, T., Sipos, F. et al. The Role of the Bone Marrow Derived Mesenchymal Stem Cells in Colonic Epithelial Regeneration. Pathol. Oncol. Res. 17, 11–16 (2011). https://doi.org/10.1007/s12253-010-9262-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-010-9262-x